Device Embolic Protection Devices

Spiderfx

Payments companies reported to CMS as associated with Spiderfx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$38Kassociated payments (2023-2025)
544clinicians with associated payments
1company reporting

By year

2023 $17K
2024 $5,346
2025 $15K

Payments reported as associated with Spiderfx, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $11K
Vascular & Interventional Radiology $9,370
Vascular Surgery $8,656
Cardiovascular Disease $3,263
Surgery $835
Diagnostic Radiology $833

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Spiderfx

These are the largest totals companies reported as associated with Spiderfx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rodney Raabe Spokane, WA Vascular & Interventional Radiology $6,700.00
Robert Minor Billings, MT Interventional Cardiology $4,500.00
Kenneth Rosenfield Boston, MA Cardiovascular Disease $650.00
Peter Schneider Honolulu, HI Vascular Surgery $600.00
John Winscott Jackson, MS Interventional Cardiology $565.42
Peter Monteleone Kyle, TX Interventional Cardiology $517.30
Sean Lyden Cleveland, OH Vascular Surgery $450.00
Karem Harth Cleveland, OH Surgery $450.00
Nicolas Mouawad West Branch, MI Vascular Surgery $450.00
Ehrin Armstrong Englewood, CO Interventional Cardiology $375.00

Prescribed Spiderfx?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.